JPMorgan downgrades Teva as generic medication business struggles

JPMorgan downgrades Teva as generic medication business struggles

Teva Pharmaceutical is hard to like as it continues to be weighed down by underperformance in some business areas, JPMorgan says. Analyst Chris Schott downgraded the stock to underweight from neutral and lowered his price target to $10 from $11, as he remains unconvinced of a long-term growth story when stacked against other pharmaceutical names. … Read more

Dow, S&P 500 set to bounce after closing at lowest levels since 2020, Dow futures up 300 points

Dow, S&P 500 set to bounce after closing at lowest levels since 2020, Dow futures up 300 points

Stock futures rose Tuesday, as the Dow Jones Industrial Average and S&P 500 tried to bounce back from their lowest closing levels in nearly two years. S&P 500 futures gained 1.1%, and Nasdaq 100 futures rose 1.3%. Those tied to the Dow Jones Industrial Average advanced 263 points, or 0.9%. The British pound rebounded slightly … Read more